Nonfatal opioid-related overdoses treated by emergency medical services in Florida, before and during the COVID-19 pandemic.
Preventive Medicine Reports · 2022-12-26 · Observational study
Abstract
Previous studies have found increases in nonfatal opioid overdoses during the COVID-19 pandemic, which created difficult conditions for people with substance use disorders. We assessed changes in nonfatal opioid-related overdoses in Florida during the onset of the COVID-19 pandemic. Emergency medical service data was obtained from the Florida Department of Health. Naloxone administration with documented improvement was used as a proxy for nonfatal opioid-related overdoses. Age-adjusted rates were estimated per 100,000 population for April-September 2020 (n = 9,377) and compared to the same time period during 2019 (n = 6,765) using rate ratios. Age-adjusted rates were estimated by sex, race/ethnicity, and metro/nonmetro county classification, as well as county-level measures of medications for opioid use disorder (MOUD) availability, rates of COVID-19 deaths, and unemployment during 2020. The age-adjusted rate of nonfatal opioid-related overdoses increased from 32.41 (95 % CL: 31.64-33.19) during 2019 to 45.35 (95 % CL: 44.42-46.27) during 2020 (RR = 1.40; 95 % CL: 1.36-1.44). The rate for males increased most in metro counties (RR = 1.47, 95 % CL: 1.41-1.53); the rate for females increased most in nonmetro counties (RR = 1.51, 95 % CL: 1.10-2.06). The largest increases were observed among Hispanics (males: RR = 1.56, 95 % CL: 1.37-1.78; females: RR = 1.44, 95 % CL: 1.14-1.81), counties with no MOUD treatment options (RR = 1.66, 95 % CL: 1.14-2.44) and counties with the lowest rates of buprenorphine prescribers (RR = 1.70, 95 % CL: 1.29-2.22). Nonfatal opioid-related overdoses increased in Florida during the first six months of the COVID-19 pandemic. Expanding access to services that support treatment and recovery is critical to addressing the ongoing opioid crisis in Florida.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · COVID-19 pandemic · Equity & disparities · Naloxone
Related articles
- Policing harm reduction: A case study of who counts as human. (Crime Media Cult, 2026)
- Barriers to calling emergency services amongst people who use substances in the event of overdose: A scoping review. (Int J Drug Policy, 2024)
- Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review. (Reg Anesth Pain Med, 2023)
- Naloxone Use, 911 Calls, and Emergency Visits After Nonfatal Overdose. (JAMA Netw Open, 2025)
- Does Housing Status Matter in Emergency Medical Services Administration of Naloxone? A Prehospital Cross-sectional Study. (West J Emerg Med, 2023)
- Importance of Analyzing Intervals to Emergency Medical Service Treatments. (Prehosp Emerg Care, 2023)